NEW YORK, April 11 - The US government has awarded Cepheid a patent for its I-CORE technology, which allows for "simultaneous, real-time optical excitation and detection of two or more nucleic acids," and one for a technology that allows for the "automated preparation of biological samples using chip-based microfluidics technology."

To date, Cepheid has 36 US patents either issued or pending, plus corresponding foreign patent applications.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.